About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Cancer Discovery
›
Top Articles
Cancer Discovery
Oncology
24.4
(top 1%)
Impact Factor
25.8
(top 1%)
extended IF
204
(top 1%)
H-Index
4.1K
authors
1.8K
papers
147.5K
citations
4.1K
citing journals
87.4K
citing authors
Most Cited Articles of Cancer Discovery
Title
Year
Citations
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data
2012
8.6K
The emergence of lncRNAs in cancer biology
2011
1.4K
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018
1.3K
AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer
2014
1.2K
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy
2011
1.2K
Patient-derived xenograft models: an emerging platform for translational cancer research
2014
1K
The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints
2015
890
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
2016
841
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
2016
840
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors
2013
831
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
2020
830
The basic principles of chimeric antigen receptor design
2013
811
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
2015
713
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy
2014
700
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
2017
692
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer
2011
668
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib
2012
663
The BATTLE trial: personalizing therapy for lung cancer
2011
660
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
2017
649
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer
2016
648
Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma
2018
648
AACR Project GENIE: Powering Precision Medicine through an International Consortium
2017
629
MYC, Metabolism, and Cancer
2015
627
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma
2014
626
Cancer cell metabolism: one hallmark, many faces
2012
609
previous
2013
2014
2015
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.